Navigation Links
VIVUS Reports Topline Findings From FORTRESS
Date:12/21/2011

e satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking Qnexa have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.

About VIVUS
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health.  The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators.  VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010.  We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012.  Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.  In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012.  For more information about the company, please visit www.vivus.com

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate,"  "expect," "intend,"  "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others.  There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.  These factors include, but are not limited to, the response from the United States Food
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. VIVUS to Present at the Credit Suisse 2011 Healthcare Conference
2. VIVUS Resubmits Qnexa NDA to the FDA
3. VIVUS Provides Regulatory Update on QNEXA
4. VIVUS Announces FDA Acceptance of Avanafil New Drug Application for Treatment of Erectile Dysfunction
5. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
6. VIVUS Reports Second Quarter and First Six Months 2011 Financial Results
7. VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results
8. VIVUS to Present at Three Upcoming Investor Conferences in March
9. VIVUS Provides Regulatory Update on QNEXA NDA
10. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
11. VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... FRANCISCO , July 2, 2015  The Green ... ), the world,s first HIPAA compliant mobile app that ... of farm-to-table fresh medical marijuana, announced today that their ... Unlike Eaze, Meadow and more than half a ... the last year, Loud Cannabis is unique in that ...
(Date:7/2/2015)... 2015   Decision Resources Group finds ... less frequent dosing as the highest unmet need ... burden on both patients and providers associated with ... injections, which are the current standard of care. ... is in development for dosing every two to ...
(Date:7/2/2015)... June 25, 2015 ... announced the addition of the "2015 ... Global Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in Clinical Chemistry and Immunodiagnostics: ... a new seven-country strategic analysis of major ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 2Retinal Specialists Indicate Strong Desire for DME Therapies Which Induce Greater Vision Gains or are Administered Less Frequently Than Currently Approved Anti-VEGF Therapies 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
(Date:7/4/2015)... ... July 04, 2015 , ... Earlier in 2015, on Feb. ... annual member survey , detailing the most common plastic surgery and minimally invasive ... raw data down into charts detailing demographic trends and regional preferences. With a ...
(Date:7/3/2015)... CA (PRWEB) , ... July 03, 2015 , ... ... opened for enrollment on July 2nd creating a buzz of media attention. In ... been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people are ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... providers, has been retained to lead a national president recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/3/2015)... TX (PRWEB) , ... July 03, 2015 , ... Jennifer ... First Choice Emergency Room , the largest network of independent freestanding emergency rooms ... new facility medical director of our Sienna Plantation facility,” said Executive Medical Director of ...
(Date:7/3/2015)... ... July 03, 2015 , ... The Celebrity Dresses is currently running a promotion ... of celebrities will have the opportunity to get 10% discount on orders that are ... do not have to use coupon codes or remember redemption codes. , There ...
Breaking Medicine News(10 mins):Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... smart and flexible behavior early in life even though ... , In a series of experiments, scientists tested how well ... of information to choose objects in a group. In some ... and in some cases based on shape. , Results showed ...
... and Inaccurate Insurance Payments Add Cost, Inefficiency to,Health ... help reduce the,substantial administrative burden of ensuring accurate ... (AMA) today,launched the Cure for Claims campaign to ... with health insurers, and unveiled the first AMA,National ...
... the world,s leading news,service for the medical technology industry ... of Parliament have been at risk of exposure to,high ... three years. This news comes despite warnings from experts ... that the material,discovered in 2005 was safely contained., ...
... called ,tastants, help you feel full, study suggests , , MONDAY, ... food with calorie-free seasonings and sweeteners may help you feel ... a U.S. study that suggests this may be a new ... of "tastants" -- substances that can stimulate the sense of ...
... detects and treats cancer cells that are resistant to ... the laboratory and could eventually prove beneficial for cancer ... The new system targets oxygen-deficient hypoxic cancer cells that ... the cells, survival and makes them unresponsive to most ...
... NEW ORLEANS, La.Positron emission tomography (PET) could be ... who are likely to respond well to treatment ... approved for use by the U.S. Food and ... Meeting. PET imaging allows practitioners to identify patients ...
Cached Medicine News:Health News:Children learn smart behaviors without knowing what they know 2Health News:Children learn smart behaviors without knowing what they know 3Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 2Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 3Health News:AMA Launches Campaign to Cut Waste From Chaotic Insurance Claims Process, Unveils New Health Insurer Report Card 4Health News:Palace of Westminster Asbestos Problem Ignored 2Health News:Flavoring Food May Promote Weight Loss 2Health News:Flavoring Food May Promote Weight Loss 3Health News:New therapy shows promise for fighting treatment-resistant cancer cells 2Health News:Every patient is unique: Individualized therapies for non-Hodgkin's lymphoma 2
... The Infinity Uric Acid single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Uric Acid reagent provides ...
... Infinity Triglycerides powder reagent once reconstituted ... of single liquid stability to help ... and provide quick result turnaround time. ... Triglycerides powder reagent provides a long ...
... The Infinity Glucose Oxidase single liquid ... the convenience of single liquid stability ... operator error and provide quick result ... the Infinity Glucose Oxidase reagent provides ...
... Infinity Glucose Hexokinase powder reagent once ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Glucose Hexokinase powder reagent provides ...
Medicine Products: